- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02380300
Registry Study of Clinical Application of MRI Compatible CIED
August 15, 2022 updated by: Biotronik (Beijing) Medical Device Ltd.
The purpose of this study is to clear the Safety and Necessity of the Magnetic Resonance Imaging (MRI) in the Presence of CIEDs(Cardiovascular Implantable Electronic Devices).
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
2067
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with ProMRI CIED implanted,including ProMRI Pacemaker/CRT and ProMRI ICD/CRTD
Description
Inclusion criteria
- Patient is >18 years old
- Patient implanted with a Biotronik MRI compatible CIED (including the pacemaker, cardiac resynchronization therapy, implantable cardioverter defibrillator, and cardiac resynchronization therapy-defibrillator) in the past two months
- Patient has provided a written informed consent
- Patient's height is≥140cm
Exclusion criteria
- Have other medical implants that may interact with MRI, e.g. abandoned pacemaker/ICD leads, lead extensions, mechanical valves, other active medical devices, non-MRI compatible devices
- Life expectancy less than 2 years
- Pregnant and/or breat-feeding females or females who intend to become pregnant in next two years
- Patient is currently participating in another study
- In the investigator's opinion patient will not be able to comply with the follow-up requirements
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Serious adverse events
Time Frame: two years
|
two years
|
The raise of Impedance Threshold of the Atrial and Ventricle
Time Frame: immediate;one month
|
immediate;one month
|
RA sensing amplitude (daily mean): < 1.5 mV or RV sensing amplitude (daily min.): < 2.0 mV
Time Frame: immediate;one month
|
immediate;one month
|
The proportion of patients with CIED who need MRI examination
Time Frame: two years
|
two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2015
Primary Completion (Actual)
September 1, 2020
Study Completion (Actual)
September 1, 2020
Study Registration Dates
First Submitted
March 2, 2015
First Submitted That Met QC Criteria
March 4, 2015
First Posted (Estimate)
March 5, 2015
Study Record Updates
Last Update Posted (Actual)
August 17, 2022
Last Update Submitted That Met QC Criteria
August 15, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 2015-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Need for MRI Imaging With Pacemaker or Implantable Cardioverter Defibrillator Implanted
-
Scripps HealthBoston Scientific Corporation; Abbott Medical Devices; Biotronik, Inc.; Scripps...CompletedNeed for MRI Imaging With Pacemaker or | Implantable Cardioverter Defibrillator ImplantedUnited States
-
Lancaster General HospitalCompletedMagnetic Resonance Imaging | Pacemaker | Implantable Cardioverter Defibrillator | MRI ScansUnited States
-
Biotronik, Inc.CompletedImplantable Cardioverter-Defibrillator With Magnetic Resonance ImagingUnited States
-
Abbott Medical DevicesCompletedThe Patient Meets ACC/AHA/ESC Guidelines for Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy (CRT-D) DeviceUnited Kingdom, Germany